Mixed lineage kinase-3 (MLK3) expression is a poor prognostic factor in diffuse large B-cell lymphoma, associated with an activated B-cell subtype

被引：0
|
作者：
Khanani, F
Almiski, MS
Basturk, O
Frank, J
Kurrer, MO
Levi, E
机构：
[1] Wayne State Univ, Harper Hosp, Detroit, MI USA
[2] Univ Hosp, Zurich, Switzerland
[3] John D Dingell VAMC, Detroit, MI USA
来源：
MODERN PATHOLOGY | 2006年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1083
引用
收藏
页码：233A / 233A
页数：1
相关论文
共 50 条
  • [1] Mixed lineage kinase-3 (MLK3) expression is a poor prognostic factor in diffuse large B-cell lymphoma, associated with an activated B-cell subtype
    Khanani, F
    Almiski, MS
    Basturk, O
    Frank, J
    Kurrer, MO
    Levi, E
    LABORATORY INVESTIGATION, 2006, 86 : 233A - 233A
  • [2] Constitutively activation of STAT3 is a prognostic factor in activated B-cell subtype of diffuse large B-cell lymphoma
    Huang, Xin
    Cao, Wenfeng
    Igbal, Javeed
    Meng, Bin
    Ding, B. Belinda
    Bi, Chengfeng
    Jiang, Chunsun
    Ye, B. Hilda
    Chan, Wing C.
    Fu, Kai
    CANCER RESEARCH, 2012, 72
  • [3] Mixed lineage Kinase-3 (MLK3) expression in follicular lymphoma
    Almiski, S.
    Razumilava, N.
    Kurrer, M.
    Levi, E.
    LABORATORY INVESTIGATION, 2008, 88 : 244A - 245A
  • [4] Mixed lineage kinase-3 (MLK3) expression in follicular lymphoma
    Almiski, S.
    Razumilava, N.
    Kurrer, M.
    Levi, E.
    MODERN PATHOLOGY, 2008, 21 : 244A - 245A
  • [5] Dasatinib Is Preferentially Active in the Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma
    Cann, Marissa L.
    Herring, Laura E.
    Haar, Lauren L.
    Gilbert, Thomas S. K.
    Goldfarb, Dennis
    Richards, Kristy L.
    Graves, Lee M.
    Lawrence, David S.
    JOURNAL OF PROTEOME RESEARCH, 2019, 18 (01) : 522 - 534
  • [6] Nur 77 Is a Poor Prognostic Factor in Diffuse Large B-Cell Lymphoma
    Almiski, Muhamad Sadek
    Kurrer, Michael
    Levi, Edi
    FASEB JOURNAL, 2008, 22
  • [7] Nur 77 is a poor prognostic factor in diffuse large B-cell lymphoma
    Almiski, S.
    Razumilava, N.
    Kurrer, M.
    Frank, J.
    Levi, E.
    LABORATORY INVESTIGATION, 2008, 88 : 245A - 245A
  • [8] Nur 77 is a poor prognostic factor in diffuse large B-cell lymphoma
    Almiski, S.
    Razumilava, N.
    Kurrer, A.
    Frank, J.
    Levi, E.
    MODERN PATHOLOGY, 2008, 21 : 245A - 245A
  • [9] MAGE-A3 expression is an adverse prognostic factor in diffuse large B-cell lymphoma
    Olarte, Irma
    Martinez, Adolfo
    Ramos-Penafiel, Christian
    Castellanos-Sinco, Humberto
    Zamora, Jorge
    Collazo-Jaloma, Juan
    Gutierrez, Mario
    Gutierrez-Kobeh, Laila
    Chavez-Olmos, Pedro
    Manzanilla, Hugo
    Garrido-Guerrero, Efrain
    Ordonez-Razo, Rosa M.
    Miranda, Enrique I.
    HEMATOLOGY, 2011, 16 (06) : 368 - 372
  • [10] Breast Diffuse Large B-cell Lymphoma, Activated B-cell like Subtype: A Case Report
    Babaria, Sneha samir
    Patel, JINAlBEN SHAIlESHBHAI
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2025, 19 (01) : ED1 - ED3
12345